UNICEF Tender Announcement: June 2024

UNICEF is planning to release a important tender in June 2024, inviting suppliers for an array of essential Beta Lactam antibiotics. This initiative is part of UNICEF’s ongoing commitment to improving global health, particularly for children and vulnerable populations. Below is a detailed list of the 11 products included in the upcoming tender:

1. Amoxicillin 125mg/5ml & 250mg/5ml Powder for Oral Suspension
Amoxicillin, a widely used antibiotic, is crucial for treating a variety of bacterial infections. The tender will include both 125mg/5ml and 250mg/5ml powder formulations for oral suspension, ensuring flexible dosing options for different age groups.

2. Amoxicillin 250mg/500mg Dispersible Tablets
These dispersible tablets are designed for ease of administration, especially in pediatric care. The tender will seek suppliers for both 250mg and 500mg strengths, providing effective treatment options for various bacterial infections.

3. Amoxicillin 250mg/500mg Tablets/Capsules
Standard tablet and capsule forms of Amoxicillin in 250mg and 500mg dosages are also part of the tender, addressing a broader range of treatment needs in both children and adults.

4. Co-Amoxiclav 125mg+31.25mg Powder for Oral Suspension
This combination antibiotic, which includes Amoxicillin and Clavulanic Acid, offers enhanced efficacy against beta-lactamase-producing bacteria. The tender will include the 125mg+31.25mg powder formulation for oral suspension.

5. Co-Amoxiclav 250mg+62.5mg Dispersible Tablets
To cater to varying needs, UNICEF will tender for Co-Amoxiclav dispersible tablets in the 250mg+62.5mg dosage. This format ensures easy administration and effective treatment.

6. Co-Amoxiclav 500mg+125mg Tablets
Higher strength Co-Amoxiclav tablets (500mg+125mg) will also be included, offering robust options for more severe infections.

7. Cefixime 200mg/400mg Tablets/Capsules
Cefixime, another essential antibiotic, will be part of the tender in both 200mg and 400mg tablet/capsule forms. This inclusion aims to provide versatile treatment options for various bacterial infections.

8. Cefixime 100mg/5ml Oral Powder for Suspension
For pediatric use, Cefixime oral powder for suspension (100mg/5ml) is also included. This formulation is particularly suitable for children who have difficulty swallowing tablets or capsules.

9. Cloxacillin 250mg/500mg Capsules
Cloxacillin, effective against certain types of staphylococcal infections, will be part of the tender in both 250mg and 500mg capsule forms.

10. Phenoxymethylpenicillin 250mg Tablets
This antibiotic, also known as Penicillin V, is included in the tender in 250mg tablet form, providing an essential option for treating streptococcal infections and other susceptible bacteria.

11. Flucloxacillin 125mg/5ml Powder for Oral Suspension
Flucloxacillin, effective against penicillin-resistant staphylococci, will be included in the tender as a 125mg/5ml powder for oral suspension, ensuring availability for pediatric treatment.

This tender represents UNICEF’s strategic effort to ensure the availability of high-quality antibiotics across the globe, addressing critical health needs in various regions. Suppliers with the capability to meet these requirements are encouraged to prepare their submissions for this upcoming opportunity in June 2024. Stay tuned for more details and official announcements on the tender process.

For further information and updates, keep an eye on UNICEF’s procurement portal and official communications. Together, we can make a significant impact on global health through reliable and accessible medical supplies.

Note:

• FindmyCustomer offers strategic partnership support for Pharma business through its company “Amedra Healthcare.” For business inquiries, please contact us at director@amedra.in
• To receive notification of such exclusive high value pharma leads at no cost, share this lead on your social media and tag us.